Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

shutterstock

Gilead’s remdesivir and three other repurposed drugs have no impact on COVID-19 mortality, WHO study finds

October 16, 2020
Medical Communications, Research and Development COVID-19, pharma, remdesivir

Gilead’s antiviral therapy remdesivir has emerged as one of the most promising drugs to treat COVID-19 infections, but recent studies …

News
pxfuel

British man suffers from permanent hearing damage after contracting COVID-19

October 14, 2020
Research and Development COVID-19, pharma

A 45-year-old man in the UK has been left with permanent hearing damage after being infected with the novel coronavirus, …

News
shutterstock_512649

Johnson & Johnson to contribute a further $1 billion to US opioid settlement

October 14, 2020
Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma

Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …

News

J&J halts COVID-19 vaccine study following unidentified participant illness

October 13, 2020
Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma

Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …

News
shutterstock_273326141

Takeda and Arrowhead Pharma join forces in $1m rare liver disease drug development pact

October 9, 2020
Medical Communications, Research and Development Arrowhead, Takeda, pharma

A new partnership has been struck between Takeda and Arrowhead Pharmaceuticals, with both companies coming together to co-develop and license …

News
shutterstock

Amgen and Cytokinetics’ drug falls short in heart failure despite hitting primary goal

October 9, 2020
Medical Communications Amgen, cytokines, heart failure, pharma

New Phase 3 data has come to light on Amgen and Cytokinetics’ cardiac myosin activator therapy omecamtiv mecarbil fell short …

News
shutterstock_138095450

Alivio Therapeutics receives $3.3m from US Department of Defense to support development of IBD drug candidate

October 5, 2020
Research and Development, Sales and Marketing Alivio, US, ibd, pharma

The US Department of Defense (DoD) has committed a Technology/Therapeutic Development Award to the value of $3.3 million to biotech …

News
shutterstock_212432119

ViiV’s two-drug regimen proves non-inferior in treatment-naive HIV-1

October 5, 2020
Research and Development, Sales and Marketing HIV-1, ViiV Healthcare, pharma

ViiV Healthcare has taken the opportunity at the HIV Glasgow 2020 Virtual Congress to unveil three-year Phase 3 data from …

News
shutter

Remdesivir has a “favourable” benefit/risk profile in COVID-19 but more data needed, DSRU review argues

October 5, 2020
Research and Development, Sales and Marketing COVID-19, Drug Safety Research Unit, pharma, remdesivir

Southampton’s Drug Safety Research Unit (DSRU) has released a systematic benefit/risk analysis of Gilead’s antiviral drug remdesivir in the treatment …

News
shutterstock_273326141

Covis Group to acquire AMAG Pharmaceuticals in $647m deal

October 5, 2020
Sales and Marketing AMAG Pharmaceuticals, Covis group, acquisition, pharma

Luxembourg-based Covis Group is set to acquire Massachusetts-based AMAG Pharmaceuticals in a new deal worth approximately $647 million on an …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

September 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The coronavirus news this week focuses on the development of treatments to alleviate symptoms of the virus, as Australian biotech …

News
pharmafocus_october_2020

The October 2020 issue of Pharmafocus is available to read free online now!

September 29, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, October 2020, Pharmafocus, digital edition, pharma

The latest monthly edition of Pharmafocus is available to read for free online now! As the US sails past the …

News
european_commission_web

Jyseleca secures European approval in rheumatoid arthritis

September 28, 2020
Research and Development, Sales and Marketing Europe, Jyseleca, arthritis, pharma

The European Commission has awarded approval to Gilead and Galpagos for their oral JAK inhibitor Jyseleca (filgotinib) as a treatment …

News
shutterstock_2

AstraZeneca and Samsung Biologics partner up in $330m manufacturing and supply deal

September 22, 2020
Manufacturing and Production AstraZeneca, Samsung BioLogics, manufacturing, pharma

AstraZeneca has announced a new global manufacturing and supply partnership with Samsung Biologics, said to be worth a potential $330.8 …

News
merckincweb

Positive five-year Keytruda survival data revealed at ESMO in metastatic, PD-L1+ non-small cell lung cancer

September 22, 2020
Manufacturing and Production, Research and Development ESMO 2020, MSD, keytruda, pharma

MSD took the opportunity at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 to unveil new Phase 3 …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026